TP53 and cancer: CRT provides dual benefit to cancer cells by upregulating prosurvival signaling (grp78) on one hand and downregulating tumor‐suppressor proteins (P53) on the other, thus playing a pivotal role in IR‐induced damage response (Figure 3D).